Group 1 - The core point of the article is that Hendi Pharmaceutical (301211) announced plans for significant share reductions by several shareholders [1] Group 2 - Shareholder Jingmen Ningkang Enterprise Management Center (Limited Partnership), holding 5.63% of shares, plans to reduce holdings by up to 4.176 million shares, representing 1% of the total share capital [1] - Shareholder Jingmen Beikang Enterprise Management Center (Limited Partnership), holding 1.88% of shares, plans to reduce holdings by up to 1.392 million shares, representing 0.33% of the total share capital [1] - Shareholder Lei Xiaoyan, holding 3.75% of shares, plans to reduce holdings by up to 4.176 million shares, also representing 1% of the total share capital [1]
亨迪药业：三名股东拟合计减持公司不超2.33%股份